Experimental drug guadecitabine found safe in patients with colorectal cancer

Posted by on April 16, 2016 1:46 pm
Categories: health

In a small, phase I clinical trial, researchers say they show for the first time that the experimental drug guadecitabine (SGI-110) is safe in combination with the chemotherapy drug irinotecan and may overcome resistance to irinotecan in patients with metastatic colorectal cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *